University Hospital Würzburg at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
University Hospital Würzburg brings 9 presentations to ASH 2026 in New Orleans. Its research centres on multiple myeloma, especially GPRC5D and CD38 therapies. Work covers talquetamab in real-world use, ataxia after GPRC5D treatment and a 3D mini-bone model of myeloma.
| Organization | ASH 2026 Attendance |
|---|---|
University Hospital Würzburg Würzburg, Germany | |
Academic hospital of the University of Würzburg in Bavaria, Germany. | Symposium Fri Dec 11 3:00pm–6:00pm The Rising Tide of Bispecifics in NHL: Off-the-Shelf Opportunities From Later-Line to Frontline Care Bispecific antibodies moving from late to early treatment of non-Hodgkin lymphoma, with outpatient step-up dosing and control of immune side effects. Oral Sat Dec 12 9:30am–11:00am Oral Sun Dec 13 9:30am–11:00am Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Oral Mon Dec 14 2:45pm–4:15pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at University Hospital Würzburg
Tell us what you sell and we’ll find the people at University Hospital Würzburg most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction